SEC 13F Intelligence

Oppenheimer Asset Management Inc. / JNJ

Oppenheimer Asset Management Inc.’s Johnson & Johnson Position

Does Oppenheimer Asset Management Inc. own Johnson & Johnson (JNJ)? Yes610.8K shares worth $149M (+1.70% of its 13F portfolio) as of Q1 2026, down from 628.2K shares the prior filed quarter.

Position Value
$149M
Q1 2026
Shares
610.8K
% of Portfolio
+1.70%
Quarters Held
30
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $63MQ4 ’18Q1 ’19: $67MQ2 ’19: $66MQ3 ’19: $60MQ4 ’19: $68MQ4 ’19Q1 ’20: $61MQ2 ’20: $64MQ3 ’20: $65MQ4 ’20: $67MQ4 ’20Q1 ’21: $71MQ2 ’21: $72MQ3 ’21: $72MQ4 ’21: $76MQ4 ’21Q1 ’22: $86MQ2 ’22: $87MQ3 ’22: $86MQ4 ’22: $91MQ4 ’22Q1 ’23: $83MQ2 ’23: $86MQ3 ’23: $79MQ4 ’23: $76MQ4 ’23Q1 ’24: $78MQ2 ’24: $84MQ3 ’24: $93MQ4 ’24: $84MQ4 ’24Q1 ’25: $109MQ2 ’25: $101MQ3 ’25: $121MQ4 ’25: $130MQ4 ’25Q1 ’26: $149Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026610.8K$149M+1.70%
Q4 2025628.2K$130M+1.60%
Q3 2025650.3K$121M+1.33%
Q2 2025659.3K$101M+1.15%
Q1 2025656.8K$109M+1.35%
Q4 2024580.6K$84M+1.02%
Q3 2024575.9K$93M+1.12%
Q2 2024573.9K$84M+1.07%
Q1 2024491.1K$78M+1.14%
Q4 2023484.6K$76M+1.06%
Q3 2023505.3K$79M+1.21%
Q2 2023517.5K$86M+1.26%
Q1 2023534.6K$83M+1.28%
Q4 2022516.3K$91M+1.47%
Q3 2022523.4K$86M+1.51%
Q2 2022488.5K$87M+1.45%
Q1 2022485.8K$86M+1.22%
Q4 2021447.1K$76M+1.01%
Q3 2021446.6K$72M+1.03%
Q2 2021438.5K$72M+1.03%
Q1 2021429.8K$71M+1.09%
Q4 2020423.6K$67M+1.11%
Q3 2020439.7K$65M+1.27%
Q2 2020452.2K$64M+1.31%
Q1 2020466.5K$61M+1.50%
Q4 2019464.5K$68M+1.43%
Q3 2019462.5K$60M+1.33%
Q2 2019472.1K$66M+1.45%
Q1 2019481.4K$67M+1.51%
Q4 2018490.5K$63M+1.57%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer Asset Management Inc.’s full portfolio or all institutional holders of JNJ.